$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Interstitial lung diseases (ILDs) constitute a group of both acute and chronic lung diseases that affect one or more of all the lung parenchymal components forming the interstitium such as bronchi, alveoli, connective tissue, and blood- and lymphatic vessels. Despite being rare diseases, the more than 200 different subtypes of ILDs represent a heterogeneous disease category with different clinical, radiological, and cyto-histological characteristics. ILDs typically manifest as inflammation, fibrosis, or a combination of both, which are the underlying causes for the patients' usual perceived symptoms as dry cough, dyspnea on exertion, and fatigue1,2.
ILDs are categorized as idiopathic interstitial pneumonia (IIP), interstitial pneumonia of known etiology (e.g., connective tissue disease interstitial lung disease, drug-induced ILD, and work-related pneumoconiosis), granulomatous interstitial affection (e.g., sarcoidosis and hypersensitivity pneumonia), and orphan ILDs (e.g., multiple cystic lung diseases and eosinophilic pneumonia)1. This categorization and further diagnostic subtyping are fundamental to determining optimal treatment and follow-up, and allow prognostication. However, as the diagnostic puzzle may be challenging, interpretation of available clinical (including anamnesis, disposition, and potential exposures) and paraclinical information as chest high-resolution computed tomography (HRCT), lung physiology, and autoimmunology obtained on the basis of a multidisciplinary team discussion (MDD) is recommended3,4,5. If a confident MDD diagnosis is not obtainable6,7, histological sampling to increase the likelihood of a definite ILD subtype diagnosis is indicated by the use of transbronchial lung cryobiopsy (TBLC)8,9. In well-selected patients, TBLC is considered a safe invasive procedure with a diagnostic accuracy close to that of video-assisted thoracic surgery lung biopsy (SLB), which is still regarded as the histological gold standard for histological ILD diagnostics10,11,12,13,14. The TBLC procedure is performed as a systematic bronchoscopy, applying special cryoprobes for histological sampling and with recommended fluoroscopic guidance. It is recommended that TBLC is performed in tertiary ILD centers using an MDD setting and by interventional pulmonologists familiar with the management of TBLC complications, who have undergone training in a dedicated center with TBLC expertise9,10,11,15,16,17.
TBLC has also recently gained attention as a procedure to be combined with radial endobronchial ultrasound (R-EBUS) for ILD diagnostics18,19. Furthermore, TBLC has been combined with both R-EBUS and electromagnetic navigation bronchoscopy (ENB) for diagnosing peripheral pulmonary lesions (PPL) to improve the diagnostic yield when compared to conventional transbronchial forceps biopsies20,21. However, this relatively novel approach for PPL diagnostics has not yet been implemented as a standard procedure and thus, warrants further evidence in this specific area. The aim of the present report is to describe a stepwise approach to conducting TBLC with a flexible bronchoscope in a clinical setting for the indications mentioned.